JBT Marel Corporation $JBTM Shares Sold by Conestoga Capital Advisors LLC

Conestoga Capital Advisors LLC decreased its position in JBT Marel Corporation (NYSE:JBTM) by 12.2% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 140,250 shares of the company’s stock after selling 19,510 shares during the period. Conestoga Capital Advisors LLC’s holdings in JBT Marel were worth $14,809,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. BlackRock Inc. acquired a new stake in JBT Marel during the 2nd quarter worth $1,150,221,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in JBT Marel by 8.5% during the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,818,441 shares of the company’s stock worth $263,674,000 after acquiring an additional 143,049 shares in the last quarter. Bamco Inc. NY acquired a new position in JBT Marel in the second quarter valued at about $95,781,000. Bank of America Corp DE increased its holdings in shares of JBT Marel by 2.3% in the first quarter. Bank of America Corp DE now owns 466,741 shares of the company’s stock worth $59,682,000 after acquiring an additional 10,714 shares in the last quarter. Finally, William Blair Investment Management LLC bought a new stake in shares of JBT Marel in the second quarter worth about $67,480,000. Institutional investors own 98.92% of the company’s stock.

JBT Marel Stock Performance

JBTM opened at $126.26 on Thursday. The company has a market capitalization of $6.55 billion, a price-to-earnings ratio of 33.67, a P/E/G ratio of 1.30 and a beta of 0.93. The business’s 50-day moving average price is $111.14 and its two-hundred day moving average price is $130.70. JBT Marel Corporation has a 1 year low of $102.97 and a 1 year high of $170.19. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.29 and a quick ratio of 0.70.

JBT Marel (NYSE:JBTM) last posted its quarterly earnings data on Tuesday, November 3rd. The company reported $2.19 earnings per share for the quarter, topping the consensus estimate of $2.09 by $0.10. The company had revenue of $994.00 million during the quarter. JBT Marel had a return on equity of 9.00% and a net margin of 5.00%. Equities analysts expect that JBT Marel Corporation will post 8.04 EPS for the current fiscal year.

Key Headlines Impacting JBT Marel

Here are the key news stories impacting JBT Marel this week:

• Positive Sentiment: Adjusted EPS was $2.19, ahead of the $2.09 consensus and up from $1.94 a year earlier. JBT Marel also raised its 2026 adjusted EPS outlook to $8.10–$8.40, supporting the earnings-growth case. Article: JBT Marel Q3 Adjusted Earnings Increase, Revenue Decreases; 2026 Adjusted EPS Guidance Lifted
• Positive Sentiment: Management set a goal of reaching a 20% adjusted EBITDA margin in 2028, signaling confidence in longer-term profitability and operating improvement. Article: JBT Marel targets 20% adjusted EBITDA margin in 2028
• Positive Sentiment: The company announced an increased share-repurchase authorization, adding a capital-return signal that may support investor sentiment. A subsequent update reported activity under the buyback plan. Article: JBT Marel reports third-quarter results and announces increased share repurchase authorization
• Neutral Sentiment: Protein Solutions showed resilience, helping offset weaker conditions in the consumer packaged goods business; the mix of performance points to uneven demand across markets. Article: JBTM Q3 deep dive
• Negative Sentiment: Quarterly revenue of $994 million came in below analyst estimates. Management also cited lower book-and-ship volume, tempering the earnings beat and improved outlook. Article: JBT Marel reports sales below analyst estimates in Q3 2026

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on JBTM shares. Robert W. Baird cut their price objective on JBT Marel from $188.00 to $171.00 and set an “outperform” rating on the stock in a report on Thursday, September 24th. Barclays initiated coverage on shares of JBT Marel in a report on Tuesday, September 8th. They set an “overweight” rating and a $150.00 target price on the stock. KeyCorp assumed coverage on shares of JBT Marel in a report on Tuesday, August 25th. They issued an “overweight” rating and a $150.00 price target for the company. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of JBT Marel in a report on Wednesday, September 2nd. Five investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, JBT Marel currently has a consensus rating of “Moderate Buy” and an average price target of $165.20.

About JBT Marel

JBT Marel Corporation (NYSE: JBTM) is a global food processing technology company formed through the combination of JBT Corporation and Marel. The company develops, manufactures and services equipment, integrated production lines and software used throughout the food industry, from primary processing to packaging and related automation.

Its products and solutions support the processing of poultry, meat, fish, prepared foods, pet food, plant-based products, fruits and vegetables, and other food categories.